Hagemoser–Weinstein–Bresnick syndrome

Hagemoser–Weinstein–Bresnick syndrome
Classification and external resources
Specialty ophthalmology, otolaryngology
ICD-10 H47.2, H90.3
OMIM 165199

Hagemoser–Weinstein–Bresnick syndrome is an autosomal dominant genetic disorder first described by Hagemoser et al. in 1989. It is characterized by optic atrophy followed shortly by loss of hearing and peripheral neuropathy. Onset of the disease occurred in early childhood, as opposed to the later onset of similar diseases. Optic atrophy occurs in the first year and the following symptoms show up before thirteen years.[1] A possible autosomal recessive form of this disease was described in 1970 by Iwashita et al.[2]

See also

References

  1. ↑ Hagemoser et. al (1989). "Optic atrophy, hearing loss, and peripheral neuropathy". American Journal of Medical Genetics. 33: 61–65. doi:10.1002/ajmg.1320330108.
  2. ↑ Iwashita, H.; Inoue, N.; Kuroiwa, Y. (1969). "Familial optic and acoustic nerve degeneration with distal amyotrophy". Lancet. 294: 219–220. doi:10.1016/s0140-6736(69)91462-7.


This article is issued from Wikipedia - version of the 9/20/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.